COVID-19

Showing 15 posts of 602 posts found.

BD’s rapid COVID-19 test granted Emergency Use Authorization by FDA

April 1, 2021
BD, COVID-19, COVID-19 testing, EUA, FDA

The FDA has granted Emergency Use Authorization (EUA) for Becton, Dickinson and Company’s (BD) rapid antigen test to be used …

COVID-19 virus

Pharmafile.com’s weekly COVID-19 news round-up

March 31, 2021
Research and Development COVID-19, covid 19 news, covid-19 news, covid-19 roundup

The past week has seen plenty of positive COVID-19 news; Starpharma are to start selling their COVID-fighting nose spray in …

Celonic to manufacture at least 100 million CureVac COVID-19 jabs

March 31, 2021
Research and Development COVID-19, COVID-19 vaccine, CureVac, colonic, vaccine production

Celonic are to manufacture more than 100 million doses of CureVac’s COVID-19 vaccine, with 50 million shots expected to be …

J & J to ship up to 400 million vaccines to Africa

March 30, 2021
Manufacturing and Production COVAX, COVID-19, COVID-19 vaccine, Janssen, Johnson & Johnson

Johnson & Johnson has reached an agreement to ship as many as 400 million doses of their COVID-19 vaccine to …

gsk_boronia_australia

GSK to support manufacture of 60m Novavax COVID-19 vaccines

March 30, 2021
Manufacturing and Production COVID-19, GSK, UK, Vaccine

GSK has reached an agreement with Novavax and the UK Government Vaccines Taskforce to support the production of up to …

moderna_norwood_plant

500,000 Moderna COVID-19 vaccines to arrive in UK next month

March 29, 2021
Sales and Marketing COVID-19, Moderna, Vaccine

More than 500,000 doses of Moderna’s COVID-19 vaccine are set to arrive in the UK next month, ministers have confirmed. …

GSK building

GSK & Vir’s COVID-19 treatment shows 85% efficacy in Phase III trial

March 29, 2021
Sales and Marketing COVID-19, GSK, Phase III trial, covid-19 treatment, vir

GSK and Vir Biotechnology have submitted an Emergency Use Authorization request to the FDA for their VIR-7831 therapy for the …

Top 10 news roundup

Pharmafile.com’s top 10 news stories of the week

March 26, 2021
Medical Communications AstraZeneca vaccine, COVID-19, covid 19 news, covid-19 news, news, news roundup, starpharma

In the last week, a number of new developments have made the news; for COVID-19, Starpharma will begin to sell …

Novavax delays 100 million vaccines to the EU

March 26, 2021
Medical Communications COVID-19, EU, Vaccine

Novavax is delaying the signing of a contract to supply COVID-19 vaccines to the EU, as the company warned it …

Pfizer's New York headquarters

Pfizer begins COVID-19 vaccine testing on young children

March 26, 2021
Medical Communications COVID-19, Pfizer, Vaccine

Pfizer have begun testing its COVID-19 vaccine on children under the age of 12, with the trials’ first participants, a …

Starpharma to sell COVID-fighting nose spray in UK

March 25, 2021
COVID-19

Australian biotech company, Starpharma, has announced a deal with LloydsPharmacy to sell its COVID-fighting antiviral nasal spray, Viraleze, in the …

Merck and UCLA find new COVID-19 treatment candidate

March 25, 2021
COVID-19, Merck, berzosertib, covid-19 treatment, ucla

Merck (MSD in the UK), the UCLA, and other universities from the US and Germany have uncovered a compound that …

AstraZeneca sign

AstraZeneca vaccine found to be 3% less effective after further trial analysis

March 25, 2021
AstraZeneca, AstraZeneca vaccine, COVID-19, COVID-19 vaccine, Vaccine

AstraZeneca have revised their findings from the US study AZD1222 of their COVID-19 vaccine, announcing a 76% efficacy against symptoms …

NHS agrees on MSD interim colorectal cancer treatment

March 25, 2021
COVID-19, Cancer, MSD, NHS

MSD has announced a provisional agreement with the NHS to make KEYTRUDA (pembrolizumab) available for eligible patients with metastatic MSI-H/dMMR …

AstraZeneca and J&J COVID-19 vaccines face viral vector shortage

March 25, 2021
Astrazenaca, COVID-19, Johnson & Johnson, Vaccine

Both AstraZeneca and J&J face major manufacturing deficiencies for their recombinant vector COVID-19 vaccines, forcing competition over limited production capacity …

The Gateway to Local Adoption Series

Latest content